W.P. Carey (WPC) Beats Q4 FFO and Revenue Estimates — Positive
WPC Zacks Investment Research — February 11, 2025W.P. Carey (WPC) came out with quarterly funds from operations (FFO) of $1.21 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to FFO of $1.19 per share a year ago.
Evolution Petroleum (EPM) Reports Q2 Loss, Lags Revenue Estimates — Negative
EPM Zacks Investment Research — February 11, 2025Evolution Petroleum (EPM) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.03 per share a year ago.
Fluence Energy (FLNC) Shares Crash 46% After Q1 2025 Results, SEC Investigation Ongoing – Hagens Berman — Neutral
FLNC GlobeNewsWire — February 11, 2025FLNC Investors with Substantial Losses Encouraged to Contact the Firm FLNC Investors with Substantial Losses Encouraged to Contact the Firm
Agree Realty (ADC) Surpasses Q4 FFO and Revenue Estimates — Positive
ADC Zacks Investment Research — February 11, 2025Agree Realty (ADC) came out with quarterly funds from operations (FFO) of $1.04 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to FFO of $1 per share a year ago.
American International Group (AIG) Tops Q4 Earnings and Revenue Estimates — Positive
AIG Zacks Investment Research — February 11, 2025American International Group (AIG) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.79 per share a year ago.
Avis Budget Group (CAR) Reports Q4 Loss, Misses Revenue Estimates — Negative
CAR Zacks Investment Research — February 11, 2025Avis Budget Group (CAR) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to earnings of $7.10 per share a year ago.
Eversource Energy (ES) Tops Q4 Earnings and Revenue Estimates — Positive
ES Zacks Investment Research — February 11, 2025Eversource Energy (ES) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.95 per share a year ago.
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates — Negative
ADPT Zacks Investment Research — February 11, 2025Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.
Upstart Holdings, Inc. (UPST) Surpasses Q4 Earnings and Revenue Estimates — Positive
UPST Zacks Investment Research — February 11, 2025Upstart Holdings, Inc. (UPST) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.11 per share a year ago.
Lyft (LYFT) Surpasses Q4 Earnings Estimates — Positive
LYFT Zacks Investment Research — February 11, 2025Lyft (LYFT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.19 per share a year ago.
Forrester Research (FORR) Q4 Earnings and Revenues Beat Estimates — Positive
FORR Zacks Investment Research — February 11, 2025Forrester Research (FORR) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.25 per share a year ago.
Compared to Estimates, Red Rock Resorts (RRR) Q4 Earnings: A Look at Key Metrics — Positive
RRR Zacks Investment Research — February 11, 2025The headline numbers for Red Rock Resorts (RRR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sensata (ST) Reports Q4 Earnings: What Key Metrics Have to Say — Neutral
ST Zacks Investment Research — February 11, 2025While the top- and bottom-line numbers for Sensata (ST) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Confluent (CFLT) Q4 Earnings: A Look at Key Metrics — Positive
CFLT Zacks Investment Research — February 11, 2025Although the revenue and EPS for Confluent (CFLT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Welltower (WELL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
WELL Zacks Investment Research — February 11, 2025The headline numbers for Welltower (WELL) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Skyworks Solutions, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Skyworks Solutions, Inc. (SWKS) — Neutral
SWKS Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Skyworks Solutions, Inc. ("Skyworks Solutions, Inc.") (NASDAQ:SWKS) concerning possible violations of federal securities laws. Skyworks issued a press release on February 5, 2025, reporting its financial results for its fiscal quarter ended December 27, 2024.
Contact Levi & Korsinsky by April 1, 2025 Deadline to Join Class Action Against Newmont Corporation(NEM) — Neutral
NEM Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128822&wire=1 or contact Joseph E. Levi, Esq.
GSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK — Neutral
GSK Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=128818&wire=1 or contact Joseph E. Levi, Esq.
Revance Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Revance Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 4, 2025 - RVNC — Neutral
RVNC Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=128819&wire=1 or contact Joseph E. Levi, Esq.
ATTENTION e.l.f. Beauty, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights — Neutral
ELF Accesswire — February 11, 2025NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of e.l.f. Beauty, Inc. ("e.l.f.
